DR. MARIS
ActiveSummary
DR. MARIS has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.09M and a net result of €294k. Equity is growing by ~13.8% per year across the filed fiscal years. Its solvency ranks better than 69% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability96=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 4.87 against 6.04 in 2024; short-term debt: 19.5% and cash: 33% of total assets), and 19.7% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
80.3%
Return on assets
21.6%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 23-04-2026, 7 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
7 d early
2024
36 d early
2023
35 d early
2022
33 d early
2021
32 d early
2020
32 d early
2019
on the day
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
26-09-2026 today30-09-2026 close30-04-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Is the workforce growing, and do people stay?Employer check
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
In the rankings
#7 company by equity in Ninove, Health and social work sector#8 company by total assets in Ninove, Health and social work sector
Equity
€1.09M▲ 19.3%
2024 · €915k
Total assets
€1.36M▲ 25.3%
2024 · €1.08M
Net result
€294k▲ 23.1%
2024 · €239k
Working capital
€1.03M▲ 21.7%
2024 · €844k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€284k▲ 61.5%€233k▼ 17.8%€262k▲ 12.3%€328k▲ 25.3%€360k▲ 9.8%
Net result€196k▲ 67.6%€173k▼ 11.8%€187k▲ 8.4%€239k▲ 27.2%€294k▲ 23.1%
Equity€674k▲ 34.4%€847k▲ 25.7%€1.03M▲ 22.1%€915k▼ 11.5%€1.09M▲ 19.3%
Total assets€720k▲ 17.3%€878k▲ 22.0%€1.05M▲ 19.9%€1.08M▲ 3.1%€1.36M▲ 25.3%
Debt€46k▼ 59.2%€31k▼ 32.4%€18k▼ 42.5%€170k▲ 853%€268k▲ 57.7%
Working capital€648k▲ 35.7%€826k▲ 27.4%€1.01M▲ 22.7%€844k▼ 16.7%€1.03M▲ 21.7%
Staff (FTE)0.3
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 10% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.36M
Fixed assets
€66k ▼ 8.9%
Current assets
€1.29M ▲ 27.8%
Equity and liabilities €1.36M
Equity
€1.09M ▲ 19.3%
Debt
€268k ▲ 57.7%
Debt's share of the balance-sheet total rises from 15.7% to 19.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€381k▲
2024 · €341k
Cash flow
€314k▲
2024 · €251k
Current ratio
4.87▼
2024 · 6.04
Debt to equity
0.25▲
2024 · 0.19
ROE
26.9%▲
2024 · 26.1%
ROA
21.6%▼
2024 · 22.0%
Interest coverage
1967.79▲
2024 · 296.65
Debt ≤ 1 year
€265k▲
2024 · €167k
Income taxes
€121k▲
2024 · €109k
Staff costs
€3k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | €8k | - | - |
| Remuneration, social security and pensions62 | - | - | - | - | €3k | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €8k | €9k | €10k | €12k | €20k | ▲ 65.4% |
| Other operating charges640/8 | - | €691 | €1k | €927 | €456 | ▼ 50.8% |
| Gross operating margin9900 | €293k | €243k | €273k | €342k | €385k | ▲ 12.6% |
| Operating profit (loss)9901 | €284k | €233k | €262k | €328k | €360k | ▲ 9.8% |
| Financial income75/76B | - | €11k | €8k | €20k | €55k | ▲ 172% |
| Recurring financial income75 | €3k | €11k | €8k | €20k | €55k | ▲ 172% |
| Financial charges65/66B | - | €382 | €3k | €1k | €193 | ▼ 83.2% |
| Recurring financial charges65 | €6k | €382 | €3k | €1k | €193 | ▼ 83.2% |
| Profit (loss) for the period before taxes9903 | €281k | €244k | €267k | €347k | €415k | ▲ 19.5% |
| Income taxes67/77 | €85k | €71k | €80k | €109k | €121k | ▲ 11.6% |
| Profit (loss) for the period9904 | €196k | €173k | €187k | €239k | €294k | ▲ 23.1% |
| Profit (loss) for the period to be appropriated9905 | €196k | €173k | €187k | €239k | €294k | ▲ 23.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €720k | €878k | €1.05M | €1.08M | €1.36M | ▲ 25.3% |
| Fixed assets21/28 | €28k | €24k | €23k | €73k | €66k | ▼ 8.9% |
| Tangible fixed assets22/27 | €28k | €23k | €23k | €73k | €66k | ▼ 9.0% |
| Plant, machinery and equipment23 | - | €6k | €4k | €2k | €1k | ▼ 18.3% |
| Furniture and vehicles24 | - | €2k | €4k | €61k | €47k | ▼ 22.3% |
| Other tangible fixed assets26 | - | €15k | €15k | €10k | €17k | ▲ 73.2% |
| Financial fixed assets28 | €420 | €420 | €420 | €420 | €420 | = |
| Current assets29/58 | €691k | €854k | €1.03M | €1.01M | €1.29M | ▲ 27.8% |
| Amounts receivable within one year40/41 | €225 | €2k | €8k | - | - | - |
| Other amounts receivable41 | - | €2k | €8k | - | - | - |
| Current investments50/53 | €270k | €316k | €496k | €844k | €844k | = |
| Cash at bank and in hand54/58 | €418k | €533k | €521k | €165k | €449k | ▲ 172% |
| Deferred charges and accrued income490/1 | - | €4k | €4k | €2k | €124 | ▼ 94.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €720k | €878k | €1.05M | €1.08M | €1.36M | ▲ 25.3% |
| Equity10/15 | €674k | €847k | €1.03M | €915k | €1.09M | ▲ 19.3% |
| Contributions10/11 | - | €6k | €6k | €1k | €1k | = |
| Reserves13 | €668k | €840k | €1.03M | €914k | €1.09M | ▲ 19.3% |
| Non-distributable reserves130/1 | - | €2k | €2k | - | - | - |
| Reserves not available under the articles1311 | - | €2k | €2k | - | - | - |
| Distributable reserves133 | - | €839k | €1.03M | €914k | €1.09M | ▲ 19.3% |
| Amounts payable17/49 | €46k | €31k | €18k | €170k | €268k | ▲ 57.7% |
| Amounts payable within one year42/48 | €43k | €28k | €15k | €167k | €265k | ▲ 58.6% |
| Financial debts43 | - | €17k | - | - | - | - |
| Credit institutions430/8 | - | €17k | - | - | - | - |
| Trade debts44 | €6k | €3k | €4k | €2k | €1k | ▼ 44.1% |
| Suppliers440/4 | - | €3k | €4k | €2k | €1k | ▼ 44.1% |
| Taxes, remuneration and social security45 | - | €1k | €993 | €40k | €40k | ▼ 1.7% |
| Taxes450/3 | - | €1k | €993 | €40k | €37k | ▼ 9.0% |
| Remuneration and social security454/9 | - | - | - | - | €3k | - |
| Other amounts payable47/48 | - | €8k | €11k | €125k | €225k | ▲ 79.9% |
| Accrued charges and deferred income492/3 | - | €3k | €3k | €3k | €3k | = |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €196k | €173k | €187k | €239k | €294k | ▲ 23.1% |
| + Depreciation and write-downs630 | €8k | €9k | €10k | €12k | €20k | ▲ 65.4% |
| Operating cash flow (approximation) | €204k | €182k | €197k | €251k | €314k | ▲ 25.2% |
| Investment in fixed assets (approximation) | - | €-4k | €-9k | €-62k | €-14k | ▲ 77.6% |
| Change in cash | - | €115k | €-12k | €-356k | €284k | ▲ 180% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Highest result since 2018net €294k ▲23.1%
Operating result €360k, net result €294k, both a record.
30-09
Financial
Equity above €1MEq €1.09M ▲19.3%
8 profitable years in a row build equity to €1.09M.
25-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
26-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Liquidity doublescurrent ratio 67.11
Current ratio from 29.98 to 67.11; short-term debt falls from €28k to €15k.
30-09
Financial
Equity above €1MEq €1.03M ▲22.1%
6 profitable years in a row build equity to €1.03M.
28-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
29-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-09
Financial
Liquidity triplescurrent ratio 15.96
Current ratio from 5.35 to 15.96; short-term debt falls from €110k to €43k.
29-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-09
Financial
Equity above €500kEq €501k ▲6.6%
3 profitable years in a row build equity to €501k.
Show earlier events
30-04
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
21-03
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
29-03
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
27-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ninove · 1 establishment unit since 2002
Ground area
2,358 m²
Building footprint
194 m²
Parcel 41045A0096/00G000, Flanders. Linked by address, not a title deed.
1 establishment unit
Brusselseheerweg 167, 9403 Ninove
since 20022.231.598.529
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41045A0096/00G000 | Flanders | 2,358 m² | 1 · 194 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Johan Crevits
BE 0458.112.291
Kortemark · Eq €1,091,444
DOKTER MAES RUDI
BE 0471.824.331
Genk · Eq €1,090,881
MAISON MEDICALE DE LAEKEN
BE 0480.633.119
Brussel · Eq €1,092,941
Dr. M. De Rick - Huisarts
BE 0442.749.768
Haacht · Eq €1,089,271
SLOCK HUISARTSENPRAKTIJK bv bvba
BE 0472.419.593
Lochristi · Eq €1,094,865
Of 9,125 companies in sector 86210 we hold annual accounts for 6,336. 3,933 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded15-07-2002
Fiscal year end30-09
Activities, NACEBEL 2025
86210General medical practice
86910Medical imaging and medical laboratories
Contact
E-mail
els.maris@telenet.beNinove
Phone
054/518580Ninove
Scores and ratios are computed by Checked and are not a credit decision.